Shortcomings in the technical documentation of mesh implants intended to treat pelvic organ prolapse used in the Netherlands After a detailed assessment of the technical documentation of 9 different mesh implants intended to treat pelvic organ prolapse used in NL (2018) RIVM concludes that the safety and performance of these products were not properly substantiated.
More reports of adverse effects of implants in 2019 In 2019, the Dutch reporting centre for adverse effects of medical implants (MEBI) received 397 reports of suspected adverse effects. The reports concerned 462 implants.
Mesh implants intended to treat pelvic organ prolapse Synthetic mesh are used to treat patients with pelvic organ prolapse.
Environmental radioactivity in the Netherlands : Results in 2017 RIVM reports annually on the level of radioactivity that occurs under normal circumstances in the environment and food.
Summary International Expert Meeting on breast implant-associated lymphoma On November 19th 2018, RIVM organised an international expert meeting on a rare type of lymphoma that is associated with breast implants.
Nanotechnology increasingly used in medical devices The application of nanotechnology to design and produce medical devices is increasing. RIVM provides an overview of nanotechnology enabled medical devices.
No new MERS patients in the Netherlands Almost two months ago, two Dutch people were diagnosed with the MERS coronavirus.
International study finds MERS coronavirus in raw dromedary camel milk Milk from dromedary camels infected with the MERS coronavirus may contain the virus, and consuming this raw milk may thus pose a risk to public health.
Clinical condition Dutch MERS patients improving The two patients who were diagnosed last week with the MERS coronavirus are now on the mend.
The MERS-coronavirus in the Netherlands As of 13 May 2014, RIVM and Erasmus MC have diagnosed the MERS coronavirus in two Dutch people. The patients are related and were infected during a joint journey to Saudi Arabia.